Chiara Corti/LinkedIn
Aug 19, 2024, 06:51
Chiara Corti: Our ASCO Daily News editorial “IMpassion132”
Chiara Corti shared a post on LinkedIn:
“Check out our American Society of Clinical Oncology (ASCO) Daily News editorial ‘IMpassion132: Learning From Immunotherapy’s Failures in Early Relapsing Triple-Negative Breast Cancer’. ”
Source: Chiara Corti/LinkedIn
More posts by Chiara Corti in OncoDaily.
Chiara Corti is currently a Clinical Research Fellow at Dana-Farber Cancer Institute in Boston, focusing on early drug development for patients with solid tumors, with a special commitment to breast cancer. Since November 2019, she has also been a Medical Oncology Fellow at the European Institute of Oncology (IEO).
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 2, 2025, 10:05
Apr 2, 2025, 09:30
Apr 2, 2025, 09:12